MSCI Ascension Shines Spotlight on Untapped Saudi Arabia

Oliver Bell, Portfolio Manager, Frontier Markets Equity Strategy

In June, Saudi Arabia was approved for an upgrade from its standalone classification to the MSCI Emerging Market Index. The country will become 2.6% of the MSCI Emerging Markets Index when it is eventually included in the benchmark in mid-2019.

Over the next three to five years, we envisage the Saudi component of the MSCI Emerging Markets Index could rise to upwards of 9-10%. The widely-expected IPO of the country’s oil giant Aramco would likely see a doubling of the initial Saudi weighting, while the country also has a pipeline of around US $150bn of potential IPOs coming to market over the coming three-to-five years—which would further increase the benchmark weighting.


As witnessed in other recently-upgraded countries, the upcoming ascension into the MSCI’s flagship EM index will likely underpin Saudi equities over the coming year and beyond, as global investors cast an eye on a market that is almost exclusively owned by domestic investors.

While the Saudi authorities have improved the prior arduous process for overseas investors to take stakes in the country’s companies over the past 18 months—in a campaign to obtain the MSCI upgrade—foreign investors still only account for about 3%1 of total market ownership. The untapped potential is huge, particularly considering average foreign ownership across the EM universe today is 14.4%2.

We have been bullish on Saudi Arabian equities for some time, largely sparked by the country’s ongoing reform programme. This has been most ambitiously outlined in the country’s Vision 2030 blueprint—an ambitious reform plan being spearheaded by Crown Prince Mohammad Bin Salman, commonly known as ‘MBS’, the heir apparent and son of King Salman.

A kingdom led by the 32-year-old MBS is an exciting prospect for the investment community, given his focus on important reform measures vital to unlocking the country’s substantial economic potential. Before MBS’ reform efforts, the business community in Saudi Arabia was too reliant on the government’s system of subsidies.


As investors, we have been very careful to find companies on the right side of change. We have identified a number of attractive investment opportunities within the country—primarily in the banking, consumer and healthcare sectors.

High quality Saudi banks—which continue to trade at the lower-end of historical valuations—are beginning to feel the effects of the improving economy, with loan growth increasing as the recent oil price rise begins to filter through.

Saudi banks are also direct beneficiaries of the US Federal Reserve’s rate hike cycle. As the Saudi riyal currency is pegged to the dollar, Saudi interest rates traditionally mimic any Fed action, which could boost bank net interest income. The sector also offers healthy, dollar-pegged, yields of 4-5%3.

We are also bullish on the prospects of the Saudi healthcare space, as the government understands the need to improve the level of care offered to its citizens. There is an acute need for the government to spend more on healthcare, as evidenced by the undersupply of hospital beds. Saudi Arabia currently has just 2.2 hospital beds per 1,000 people—below the 2.5 global average and far lower than the 6.3 average in Europe4.

Key Risks—The following risks are materially relevant to the strategy highlighted in this material: Transactions in securities denominated in foreign currencies are subject to fluctuations in exchange rates which may affect the value of an investment. Returns can be more volatile than other, more developed, markets due to changes in market, political and economic conditions. Investments are less liquid than those which trade on more established markets.

1HSBC, 31st March 2018

2Tadawul Exchange, 31st December 2017

3T. Rowe Price analysis

4Morgan Stanley Research, July 2016

Important Information

The specific securities identified and described above do not necessarily represent securities purchased or sold by T. Rowe Price. This information is not intended to be a recommendation to take any particular investment action and is subject to change. No assumptions should be made that the securities identified and discussed above were or will be profitable.

This material is being furnished for general informational purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice, and prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested.

The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction.

Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources’ accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date written and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.

The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request.

It is not intended for distribution to retail investors in any jurisdiction.

USA—Issued in the USA by T. Rowe Price Associates, Inc., 100 East Pratt Street, Baltimore, MD, 21202, which is regulated by the U.S. Securities and Exchange Commission. For Institutional Investors only.

T. ROWE PRICE, INVEST WITH CONFIDENCE, and the bighorn sheep design are, collectively and/or apart, trademarks of T. Rowe Price Group, Inc. © 2018 T. Rowe Price. All rights reserved.




Latest Date Range
Audience for the document: Share Class: Language of the document:
Download Cancel


Share Class: Language of the document:
Download Cancel
Sign in to manage subscriptions for products, insights and email updates.
Continue with sign in?
To complete sign in and be redirected to your registered country, please select continue. Select cancel to remain on the current site.
Continue Cancel
Once registered, you'll be able to start subscribing.

Change Details

If you need to change your email address please contact us.
You are ready to start subscribing.
Get started by going to our products or insights section to follow what you're interested in.

Products Insights

GIPS® Information

T. Rowe Price ("TRP") claims compliance with the Global Investment Performance Standards (GIPS®). TRP has been independently verified for the twenty one- year period ended June 30, 2017 by KPMG LLP. The verification report is available upon request. Verification assesses whether (1) the firm has complied with all the composite construction requirements of the GIPS standards on a firm-wide basis and (2) the firm's policies and procedures are designed to calculate and present performance in compliance with the GIPS standards. Verification does not ensure the accuracy of any specific composite presentation.

TRP is a U.S. investment management firm with various investment advisers registered with the U.S. Securities and Exchange Commission, the U.K. Financial Conduct Authority, and other regulatory bodies in various countries and holds itself out as such to potential clients for GIPS purposes. TRP further defines itself under GIPS as a discretionary investment manager providing services primarily to institutional clients with regard to various mandates, which include U.S, international, and global strategies but excluding the services of the Private Asset Management group.

A complete list and description of all of the Firm's composites and/or a presentation that adheres to the GIPS® standards are available upon request. Additional information regarding the firm's policies and procedures for calculating and reporting performance results is available upon request

Other Literature

You have successfully subscribed.

Notify me by email when
regular data and commentary is available
exceptional commentary is available
new articles become available

Thank you for your continued interest